XML 39 R45.htm IDEA: XBRL DOCUMENT v3.20.1
DESCRIPTION OF BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition and Costs of Sales and Vendor Allowances (Details) - USD ($)
$ in Millions
3 Months Ended 4 Months Ended 12 Months Ended
Feb. 29, 2020
Feb. 29, 2020
Nov. 30, 2019
Sep. 07, 2019
Feb. 23, 2019
Dec. 01, 2018
Sep. 08, 2018
Jun. 15, 2019
Jun. 16, 2018
Feb. 29, 2020
Feb. 23, 2019
Feb. 24, 2018
Deferred Revenue Arrangement [Line Items]                        
Receivables, net $ 525.3 $ 525.3     $ 586.2         $ 525.3 $ 586.2  
Contract liability 52.2 52.2     55.9         52.2 55.9  
Net sales and other revenue 1,100.0 15,436.8 $ 14,103.2 $ 14,176.7 14,016.6 $ 13,840.4 $ 14,024.1 $ 18,738.4 $ 18,653.4 62,455.1 60,534.5 $ 59,924.6
Reduction of inventory for Vendor Allowance 72.0 72.0     74.8         72.0 74.8  
Advertising costs                   405.6 422.3 497.5
Cooperative advertising allowances                   91.9 101.3 81.1
Pharmacy                        
Deferred Revenue Arrangement [Line Items]                        
Receivables, net $ 218.5 $ 218.5     $ 252.2         218.5 252.2  
Net sales and other revenue                   $ 5,236.8 $ 4,986.6 $ 5,002.6